Ò½ÏßÒ©ÎÅ

1. 9ÔÂ3ÈÕ£¬Èüŵ·ÆÐû²¼ÌæÀûÖéµ¥¿¹×¢ÉäÒº£¨teplizumab£©»ñÅúÉÏÊУ¬ÓÃÓÚÑÓ»º³ÉÈ˺Í8Ëê¼°ÒÔÉ϶ùͯ1ÐÍÌÇÄò²¡»¼Õß´Ó2ÆÚÏ£ÍûÖÁ3ÆÚ¡£ÌæÀûÖéµ¥¿¹ÊÇMacroGenics¿ª·¢µÄÒ»¿îCD3µ¥¿¹¡£

2. 9ÔÂ2ÈÕ£¬CDE ¹«Ê¾£¬°ÙÀûÌìºã×ÔÑÐ EGFR/HER3 Ë«¿¹ ADC Ò©Îï BL-B01D1 ÄâÄÉÈëÍ»ÆÆÐÔÁÆ·¨£¬ÓÃÓÚÖÎÁƲ¬ÄÍÒ©¸´·¢ÉÏƤÐÔÂѳ²°©¡¢ÊäÂѹܰ©»òÔ­·¢ÐÔ¸¹Ä¤°©¡£´ËÇ° BL-B01D1 ÒÑÀֳɻñµÃ 5 ÏîÍ»ÆÆÐÔÁÆ·¨£¬Ë³Ó¦Ö¢°üÀ¨±ÇÑÊ°©¡¢·ÇÁÛ×´·ÇСϸ°û·Î°©»¼Õß¡¢EGFR Ò°ÉúÐÍ·ÇСϸ°û·Î°©»¼¡¢Ê³¹ÜÁÛ°©ºÍСϸ°û·Î°©µÈ¡£´Ë´ÎÊÇ BL-B01D1 ÉêÇëµÄµÚ 6 ÏîÍ»ÆÆÐÔÁÆ·¨¡£

3. 9ÔÂ2ÈÕ£¬¸´ºêººÁØÓëOrganonÅäºÏÐû²¼£¬ÃÀ¹úFDAÒÑÅú×¼µØÊæµ¥¿¹×¢ÉäÒº£¨60mg/mL£©BILDYOS?£¨denosumab-nxxp£©ºÍµØÊæµ¥¿¹×¢ÉäÒº£¨120mg/1.7mL£©BILPREVDA?£¨denosumab-nxxp£©µÄÉÏÊÐÉêÇë¡£Á½¿î²úÆ·»®·ÖΪPROLIA?£¨denosumab£©ºÍXGEVA?£¨denosumab£©µÄÉúÎïÀàËÆÒ©£¬´Ë´Î»ñÅúÁýÕÖÔ­ÑвúÆ·ÔÚÃÀ¹úÒÑ»ñÅúµÄËùÓÐ˳Ӧ֢¡£BILDYOSÊÇÒ»ÖÖRANKÅäÌ壨RANKL£©ÒÖÖƼÁ£¬ÊÊÓÃÓÚÒÔÏÂÈËȺ£ºÖÎÁƾø¾­ºó¸¾Å®µÄ¸ßΣº¦¹ÇÖÊËÉÉ¢Ö¢£»ÔöÌí¹ÇÁ¿ÖÎÁƼ°Ô¤·À¹ÇÕÛ¸ßΣº¦µÄÌÇƤÖʼ¤ËØÒýÆðµÄÅ®ÐÔÓëÄÐÐÔ¹ÇÖÊËÉÉ¢Ö¢£»½ÓÊÜÐÛ¼¤ËØ°þ¶áÖÎÁÆ£¨ADT£©µÄ¹ÇÕÛ¸ßΣº¦µÄ·ÇתÒÆÐÔÇ°ÏßÏÙ°©ÄÐÐÔ»¼ÕßµÄÔöÌí¹ÇÁ¿ÖÎÁÆ£»ÒÔ¼°½ÓÊÜ·¼ÏãøÒÖÖƼÁ¸¨ÖúÖÎÁƵķÇתÒÆÐÔÈéÏÙ°©Å®ÐÔ»¼ÕßµÄÔöÌí¹ÇÁ¿ÖÎÁÆ¡£BILPREVDAÊÇÒ»ÖÖRANKÅäÌ壨RANKL£©ÒÖÖƼÁ£¬ÊÊÓÃÓڶ෢ÐÔ¹ÇËèÁö»¼ÕߺÍʵÌåÁö¹ÇתÒÆ»¼ÕߵĹÇÏà¹ØÊÂÎñ£¬Ò²ÊÊÓÃÓڹǾÞϸ°ûÁö»¼ÕßÒÔ¼°¶ñÐÔÖ×ÁöÏà¹Ø¸ß¸ÆѪ֢µÄÖÎÁÆ¡£

4. 9ÔÂ2ÈÕ£¬¾ýʵÉúÎïÐû²¼Í¨¸æ£¬Æä¿Ø¹É×Ó¹«Ë¾ÉϺ£¾ýÍØÉúÎïÒ½Ò©¿Æ¼¼ÓÐÏÞ¹«Ë¾JT118×¢ÉäÒº»ñÅúÁÙ´²¡£JT118ÊÇÓɺﶻ²¡¶¾¿¹Ô­A35£¨°ûÍâÄÒĤ²¡¶¾¿¹Ô­£©ºÍM1£¨°ûÄÚ³ÉÊ첡¶¾¿¹Ô­£©´®ÁªÈÚºÏ×é³ÉµÄ¡°¶þºÏÒ»¡±ÖØ×éÂÑ°×ÒßÃ磬ÄâÖ÷ÒªÓÃÓÚÔ¤·Àºï¶»²¡¶¾Ñ¬È¾¡£

ͶÈÚÒ©ÊÂ

1. 9ÔÂ2ÈÕ£¬Arrowhead Ðû²¼Óëŵ»ª´ïÓñ³ÉÇòÔÊÐíºÍÏàÖúЭÒ飬ÅäºÏ¿ª·¢ÓÃÓÚÖÎÁÆÅÁ½ðÉ­²¡µÈÍ»´¥ºËÂѰײ¡µÄ siRNA ÁÆ·¨ ARO-SNCA¡£Æ¾Ö¤Ð­Ò飬ŵ»ª½«»ñµÃ ARO-SNCA µÄÈ«Çò¶À¼ÒÊÚȨ£¨°üÀ¨ÔÊÐí£¬Ñо¿¡¢¿ª·¢¡¢ÖÆÔìºÍÉÌÒµ»¯£©£¬²¢½«Ê¹ÓÃÁ¢ÒìµÄ°ÐÏò RNAi ·Ö×Óƽ̨£¬ÔÚ Arrowhead ÏÖÓÐÏîÄ¿Ö®ÍâÈ·¶¨¸ü¶àÏàÖú°Ðµã¡£×÷ΪÉúÒâµÄÒ»²¿·Ö£¬Arrowhead ½«»ñµÃ 2 ÒÚÃÀÔªµÄÊ׸¶¿î£¬²¢ÓÐ×ʸñ»ñµÃ¸ß´ï 20 ÒÚÃÀÔªµÄDZÔÚÀï³Ì±®¸¶¿îÒÔ¼°ÉÌÒµÏúÊÛµÄÌØÐíȨʹÓ÷Ñ¡£¸ÃÉúÒâÔ¤¼Æ½«ÓÚ 2025 ÄêÏ°ëÄêÍê³É¡£

¿Æ¼¼Ò©ÑÐ

1. 9ÔÂ1ÈÕ£¬±±¾©´óѧÖ×ÁöÒ½ÔºQimin Zhan¡¢Jie ChenͨѶÔÚ¡¶Signal transduction and targeted therapy¡·½ÒÏþÂÛÎÄ¡°Focal adhesion kinase/Src family kinase axis-mediated tyrosine phosphorylation of metabolic enzymes facilitates tumor metastasis¡±£¬Õ¹ÏÖÁËð¤×Å°ß¼¤Ã¸£¨FAK£©/Src¼Ò×弤ø£¨SFK£©Öáͨ¹ýÀÒ°±ËáÁ×Ëữµ÷¿Ø´úлҪº¦Ã¸¡ª¡ªATP-ÄûÃÊËáÁѽâø£¨ACLY£©Tyr542/Tyr652ºÍ¹ûÌǶþÁ×ËáÈ©ËõøA£¨ALDOA£©Tyr174/Tyr302/Tyr328£¬´Ó¶øÔö½øÖ×ÁöÏ£ÍûºÍתÒÆÉúÑĵĻúÖÆ¡£¡£

[1]Chen, J., Zhang, J., Zhu, Y. et al. Focal adhesion kinase/Src family kinase axis-mediated tyrosine phosphorylation of metabolic enzymes facilitates tumor metastasis. Sig Transduct Target Ther 10, 280 (2025). https://doi.org/10.1038/s41392-025-02395-5